MARATTO

article · Experimental Parasitology

Therapeutic potential of spiramycin-nanoparticles and Aluvia in experimental congenital toxoplasmosis

In plain language

No abstract is available for this record, so no summary has been generated.

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.exppara.2025.109069

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.